MedPath

Test-retest repeatability of quantitative radiomics features of FDG PET/CT studies in patients with diffuse large B cell lymphoma

Recruiting
Conditions
diffuse large B cell lymphoma
lymph node cancer
10025320
Registration Number
NL-OMON48134
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Patient age 18 years or older
- Diagnosed with diffuse large B cell lymphoma
- At least one tumour with diameter > 3cm (to minimize partial volume effects)
- Able to remain supine for 60 minutes in the PET-CT scanner
- Written and signed informed consent

Exclusion Criteria

- Chemotherapy in the past 4 weeks
- Multiple malignancies
- Pregnant or lactating patients
- Metal implants (e.g. pacemakers)
- Any medical, physiological or social condition that may interfere with the
subject*s safety and participation in the study, will lead to exclusion from
this study

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The test-retest repeatability of radiomics features with different image<br /><br>reconstruction settings. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable </p><br>
© Copyright 2025. All Rights Reserved by MedPath